Prevest Denpro Ltd (PREVEST) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Prevest Denpro Ltd on NSE and BSE, with an AI summary of each filing.
Scrutinizer report and Voting results of the AGM held on September 17, 2026.
Annual General Meeting · 19 Sept 2026, 11:59 pm
Proceeding of the AGM held on September 17, 2026
Annual General Meeting · 17 Sept 2026, 11:27 pm
The Company has sent letter to the shareholders for AGM whose email id was not registered with RTA.
Annual General Meeting · 20 Aug 2026, 11:11 pm
Please find enclosed herewith Annual Report for Financial year 25-26.
Others (Uncategorized) · 20 Aug 2026, 8:20 pm
27th AGM of the Company is scheduled to be held on Thursday, September 17, 2026 at 12:30 p.m. through VC/OAVM.
Annual General Meeting · 20 Aug 2026, 7:07 pm
Press Release regarding Financial Results of the Company for the quarter ended June 30, 2026, along with the declaration of dividend at the rate of 10% i.e. Rs. 1/- per Equity Share.
Press Release · 11 Aug 2026, 11:33 pm
Prevest Denpro Reports Strong Q1 FY27; Declares ₹1 Dividend Prevest Denpro reported strong Q1 FY27 results, with consolidated PAT growing 27.99% YoY to ₹563.86 lakh. Consolidated revenue from operations increased 20.94% YoY to ₹1,906.83 lakh. EBITDA saw a 24.73% YoY rise to ₹808.14 lakh. The performance was driven by sustained product demand and operational efficiency. The Board has also declared a dividend of 10%, amounting to ₹1 per equity share, for the quarter ended 30 Jun'26, subject to shareholder approval.
Notice of Record Date.
Dividend · 11 Aug 2026, 11:27 pm
Prevest Denpro Sets Record Date for FY26 Final Dividend Prevest Denpro (Scrip: 543363) has fixed Sat, 5th Sep'26 as the Record Date for its final dividend for the financial year 2025-26. The dividend payment is subject to shareholder approval at the company's 27th Annual General Meeting. This action falls under Regulation 42 of the SEBI (LODR) Regulations, 2015.
The Board of Directors at its Meeting held today i.e. August 11, 2026 have considered and approved the unaudited financial results of the Company (standalone and consolidated) for quarter ....
Financial Result · 11 Aug 2026, 11:18 pm
Prevest Denpro Q1 FY27 PAT Rises 28% YoY; Board Recommends Dividend Prevest Denpro reported a 28.0% YoY rise in consolidated PAT to ₹563.86 lakh for the quarter ended 30-Jun'26, driven by a 21.0% YoY increase in revenue from operations to ₹1,906.83 lakh. Sequentially, PAT declined by 3.1% QoQ. Total expenses grew 17.2% YoY to ₹1,282.47 lakh. Basic EPS stood at ₹4.70, up from ₹3.67 YoY. The Board recommended a final dividend of ₹1.00 per share (10%) for FY26, subject to shareholder approval at the upcoming AGM.
The Company at its Board Meeting held today i.e. August 11, 2026 have approved Unaudited Financial Results of the Company (standalone and consolidated) for quarter ended June 30, 2026 and ....
Outcome · 11 Aug 2026, 11:07 pm
Prevest Denpro Ltd - Financial Result for the Quarter ended 30th Jun'26 (Consolidated, INR Lakh) ■ Revenue: 1,907 (+20.9% YoY | +0.7% QoQ) ■ EBITDA: 677 (+27.3% YoY | -2.1% QoQ) ■ EBITDA Margin (%): 35.5 (+178 bps YoY | -100 bps QoQ) ■ PAT: 564 (+28.0% YoY | -3.1% QoQ) ■ EPS (INR): 4.70 (+28.1% YoY | -3.1% QoQ)
Prevest Denpro Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve Unaudited Standalone and Consolidated ....
Intimation · 11 Aug 2026, 5:30 am
Prevest Denpro Board Meeting on 11 Aug'26 for Q1 Results, Dividend Prevest Denpro (Scrip: 543363) has scheduled a Board of Directors meeting on 11 Aug'26. The agenda includes consideration and approval of the unaudited standalone and consolidated financial results for the quarter ended 30 Jun'26 (Q1 FY27). Additionally, the board will consider a recommendation for the final dividend for the financial year 2025-26. This meeting is crucial for assessing the company's Q1 performance and its shareholder return policy for FY26.
Transcript for Earning''s call held on 29th June, 2026
Transcript · 02 Jul 2026, 4:35 pm
Pursuant to Regulation 30 and 46 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 read along with SEBI (Listing Obligations & Disclosure Requirements) (Second ....
Audio / Video · 29 Jun 2026, 10:46 pm
Prevest Denpro Publishes Q4 & FY26 Earnings Call Recording Prevest Denpro has released the audio recording of its investor and analyst earnings call held on 29 Jun'26. The call discussed the company's financial performance for the quarter and full fiscal year ended 31 Mar'26. This disclosure complies with SEBI's Listing Obligations and Disclosure Requirements Regulations. The recording is accessible via a link provided in the official filing to the BSE.
Investor Presentation to be made to Analysts/Investor on the Financial Results for financial year ended March 31, 2026
Investor Presentation · 27 Jun 2026, 11:02 pm
Prevest Denpro FY26 Results: Strong Growth and Margin Expansion Prevest Denpro reported strong FY26 results with standalone revenue from operations up 13.6% YoY to INR 7,166 lakhs, driven by operational efficiencies. Standalone EBITDA grew 16.6% YoY, with margins expanding 80 bps to 39.8%. PAT increased 17.6% to INR 2,142 lakhs. Q4 FY26 showed strong momentum, with standalone EBITDA growing 15.9% QoQ. Consolidated revenue rose 13.9% YoY to INR 7,180.85 lakhs, while PAT grew 12.9% to INR 2,049.05 lakhs. Strategic priorities include global expansion, R&D, and new product lines.
Intimation of Earnings Discussion is rescheduled to be held on June 29, 2026 at 03:00 p.m.
Intimation · 23 Jun 2026, 11:04 pm
Prevest Denpro Reschedules Q4 & FY26 Earnings Call for 29th Jun'26 Prevest Denpro has rescheduled its previously cancelled earnings discussion for the quarter and financial year ended 31st Mar'26. The analyst and institutional investor conference call will now take place on Monday, 29th Jun'26, at 3:00 PM to discuss the company's operational and financial performance. Key management, including the WTD & CFO, Director of R&D, and CMO, will participate. The event is organized by Hem Securities.
This is to inform you that the Earnings conference call scheduled to be held on June 02, 2026 has been cancelled due to unforeseen circumstances.
Intimation · 02 Jun 2026, 4:00 pm
Prevest Denpro Cancels Q4FY26 Earnings Conference Call Prevest Denpro Limited (Scrip No. 543363) has cancelled its scheduled earnings conference call, originally set for 02 Jun'26. The call was intended to discuss financial performance and operational updates for the quarter and year ended 31 Mar'26. The company cited "unforeseen circumstances" as the reason for the cancellation in its filing dated 29 May'26. No new date has been announced.
Intimation of Analyst / Institutional Investor Meeting to be held on, Tuesday, 02nd June 2026 at 4.00 PM.
Intimation · 02 Jun 2026, 4:00 pm
Prevest Denpro Schedules Q4 & FY26 Earnings Call for 02 Jun'26 Prevest Denpro Limited (Scrip No. 543363) has scheduled an earnings conference call on 02 Jun'26 at 4:00 PM to discuss its operational and financial performance for the quarter and year ended 31 Mar'26. Key management, including the Chairman & MD and the CFO, will participate. The event is organised by Hem Securities Ltd.
The Company has appointed M/s. ADV & Associates, Chartered Accountants as Statutory Auditor of the Company for a period of 5 years, subject to approval of Members of the Company.
Change in Auditor · 28 May 2026, 1:03 am
Prevest Denpro Appoints Statutory, Internal, and Other Key Auditors Prevest Denpro's board, on 27 May'26, appointed several auditors for FY27. M/s. ADV & Associates were named Statutory Auditor for a five-year term from FY27 to FY31, subject to member approval. M/s. VNB and Company were appointed Internal Auditor, M/s. PAN and Associates as Cost Auditor, and M/s. NKM and Associates as Secretarial Auditor, all for the FY27 financial year. The appointments were based on the Audit Committee's recommendation.
The Company at its meeting held today i.e., May 27, 2026 has appointed Internal Auditor, Cost Auditor, Secretarial Auditor and Statutory Auditor of the Company.
Change in Auditor · 28 May 2026, 1:01 am
Prevest Denpro Appoints Statutory, Internal, and Other Key Auditors Prevest Denpro's board, on May 27, '26, approved key auditor appointments for FY27. M/s. ADV & Associates were named Statutory Auditor for a five-year term from FY27 to FY31. For FY27, the company appointed M/s. VNB and Company as Internal Auditor, M/s. PAN and Associates as Cost Auditor, and M/s. NKM and Associates as Secretarial Auditor. These appointments follow the recommendation of the Audit Committee and are subject to member approval where applicable.
The Company at its meeting held today i.e., May 27, 2026 has appointed Mr. Sukhen Pal Babuta as Additional Director (Non Executive Independent Director) of the Company.
Change in Management · 28 May 2026, 12:50 am
Prevest Denpro Appoints Mr. Sukhen Pal Babuta as Non-Executive Independent Director Prevest Denpro (BSE: 543363) has appointed Mr. Sukhen Pal Babuta as an Additional Director in a Non-Executive Independent Director capacity, effective from 27 May'26. The appointment is for a five-year term and is subject to shareholder approval. Mr. Babuta is a chartered accountant and insolvency professional, having previously served as a director on the board of Punjab & Sind Bank. He is not related to any existing directors or key management personnel and is not debarred by any SEBI order.
The Company at its meeting held today i.e., May 27, 2026, has appointed Mr. Pratul Gupta as Company Secretary and Compliance Officer of the Companty
Change in Management · 28 May 2026, 12:46 am
Prevest Denpro Appoints New Company Secretary & Compliance Officer Prevest Denpro Limited (BSE: 543363) has appointed Mr. Pratul Gupta as the Company Secretary & Compliance Officer, effective 27 May'26. The appointment was approved by the Board of Directors based on the Nomination and Remuneration Committee's recommendation. Mr. Gupta is a qualified Company Secretary with extensive experience in corporate compliance, SEBI regulations, and secretarial operations across listed companies, unlisted entities, and NBFCs. This is a key management personnel appointment pursuant to SEBI Listing Regulations.
Audited Financial Results of the Company for quarter and financial year ended March 31, 2026
Financial Result · 28 May 2026, 12:34 am
Prevest Denpro Reports 17.6% YoY Net Profit Growth for FY26 Prevest Denpro reported strong FY26 results with consolidated net profit rising 12.9% YoY to ₹2,049.05 Lakhs and standalone net profit up 17.6% YoY to ₹2,141.82 Lakhs. For the quarter ending 31 Mar'26, consolidated PAT was ₹582.13 Lakhs versus ₹514.10 Lakhs YoY. Standalone Q4 PAT stood at ₹606.37 Lakhs. The Board approved the audited financial results on 27 May'26, which received an unmodified opinion from the auditors. Total consolidated assets grew 18.4% YoY to ₹13,319.07 Lakhs.
The Board of Directors at its Meeting held today have approved Audited Financial Results of the Company for quarter and financial year ended March 31, 2026
Outcome · 28 May 2026, 12:28 am
Prevest Denpro Ltd - Financial Result for the Quarter ended 31st Mar'26 (Consolidated, INR Lakh) ■ Revenue: 1,894 (+2.6% YoY | +2.6% QoQ) ■ EBITDA: 691 (+5.5% YoY | +19.1% QoQ) ■ EBITDA Margin (%): 36.5 (+100 bps YoY | +505 bps QoQ) ■ PAT: 582 (+13.2% YoY | +23.3% QoQ) ■ EPS (INR): 4.85 (+13.3% YoY | +23.4% QoQ)
Prevest Denpro Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2026 ,inter alia, to consider and approve Audited Financial Results of ....
Intimation · 27 May 2026, 5:30 am
Prevest DenPro Board Meeting Set for May 27 to Approve Q4FY26 Results Prevest DenPro Limited (BSE: 543363) has scheduled a Board of Directors meeting on 27 May'26. The agenda includes the consideration and approval of audited standalone and consolidated financial results for the quarter and financial year ended 31 Mar'26. In accordance with insider trading regulations, the trading window for designated persons has been closed since 01 Apr'26 and will reopen 48 hours after the financial results are publicly declared to the stock exchange.
The Board of Directors has approved subscription to the share capital of Prevest Denpro Gulf General Trading LLC, a wholly owned subsidiary for a amount upto AED 5,00,000 to be invested ....
Others (Uncategorized) · 06 May 2026, 12:00 am
Prevest Denpro to Invest AED 500,000 in UAE Subsidiary Prevest Denpro's board approved an investment of up to AED 500,000 in its UAE-based, wholly-owned subsidiary, Prevest Denpro Gulf General Trading LLC. The investment, to be made via cash subscription in one or more tranches, aims to expand the company's overseas business operations in import, export, and general trading. The transaction is classified as a related-party transaction at arm's length. Completion of the acquisition is expected by Mar '28. The subsidiary has yet to commence business operations.
Cessation of Mr. Pardeep Gandotra as Independent Director of the Company due to completion of tenure.
Change in Management · 27 Apr 2026, 5:16 pm
Prevest Denpro: Independent Director Ceases Tenure Prevest Denpro Limited announced that Mr. Pardeep Gandotra (DIN: 08733719) has ceased to be an Independent Director. The cessation is effective from the close of business hours on 26 Apr'26, following the completion of his tenure. This change in directorship was formally disclosed pursuant to Regulation 30 of SEBI Listing Regulations. The company confirmed the reason for the change was the natural conclusion of his term of appointment.